The breast ultrasound market size has grown rapidly in recent years. It will grow from $3.09 billion in 2025 to $3.49 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to reliance on conventional 2D ultrasound systems, limited access to automated imaging technologies, growing awareness of breast cancer screening, increasing hospital infrastructure for imaging, advancements in doppler ultrasound applications.
The breast ultrasound market size is expected to see rapid growth in the next few years. It will grow to $5.58 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to integration of abUS with full-field digital mammography (ffdm), development of mobile and compact ultrasound units, rising adoption of 3d/4D imaging in hospitals, growth of preventive healthcare and screening programs, increasing investment in diagnostic imaging laboratories. Major trends in the forecast period include rising adoption of automated breast ultrasound (abus) systems, increasing use of portable and handheld ultrasound devices, growth in 3D and 4D ultrasound technologies, expansion of diagnostic imaging laboratories, focus on early breast cancer detection and screening programs.
The rising incidence of breast cancer is anticipated to drive the growth of the breast ultrasound market. Breast cancer originates in breast tissue and can spread to nearby areas or other parts of the body. The increase in breast cancer cases is linked to greater exposure to lifestyle-related risk factors, such as obesity, which affects hormone levels and encourages cancer development. Breast ultrasound plays a crucial role in addressing this rise by offering a reliable, non-invasive method for early detection and precise differentiation of breast abnormalities, particularly in dense breast tissue. For example, in October 2024, the American Cancer Society, a US-based cancer organization, reported that in 2022, there were an estimated 287,850 new cases of invasive breast cancer and 51,400 cases of ductal carcinoma in situ (DCIS) diagnosed among women in the United States. These numbers are expected to increase to approximately 310,720 invasive cases and 56,500 DCIS cases by 2024. This growing incidence is therefore fueling demand in the breast ultrasound market.
Leading companies in the breast ultrasound market are concentrating on developing advanced AI-powered breast ultrasound systems (BUS) to enhance diagnostic speed and early detection, especially for women with dense breast tissue. AI-integrated automated breast ultrasound systems (ABUS) incorporate artificial intelligence to support automated image capture, real-time quality assessment, and lesion detection, thereby reducing scan variability and reliance on operator skill. For instance, in March 2025, GE HealthCare, a US-based healthcare IT provider, launched the Invenia ABUS Premium, a patient-friendly 3D automated breast ultrasound system. This system received premarket approval from the U.S. FDA to improve detection sensitivity when used alongside mammography, addressing challenges related to dense breast tissue masking cancers in conventional screenings. Features include advanced AI tools such as Verisound AI for scan quality evaluation, automatic nipple detection, and a Fast Scan function that speeds scanning by up to 40%. Its non-invasive design also enhances patient comfort, lowers unnecessary biopsies, and eliminates radiation exposure.
In June 2025, RadNet Inc., a US-based provider of diagnostic imaging and digital health services, acquired See-Mode Technologies for an undisclosed sum. This acquisition enables RadNet to integrate See-Mode’s technology into its DeepHealth population health solutions, strengthening its position in AI-driven ultrasound innovation and addressing high demand and capacity challenges in ultrasound imaging. See-Mode Technologies is a Singapore-based company specializing in AI for breast ultrasound imaging.
Major companies operating in the breast ultrasound market are Samsung Electronics Co Ltd, Hitachi Ltd, Siemens Healthineers, Koninklijke Philips NV, GE Healthcare, Hologic Inc, Mindray Medical International Limited, Canon Medical Systems Corporation, Carestream Health Inc, Fujifilm Sonosite Inc, Esaote SpA, Sonoscape Medical Corp, Shantou Institute of Ultrasonic Instruments, Terason, Delphinus Medical Technologies Inc, SonoCine Inc, Clarius Mobile Health Corp, QT Imaging Inc, QView Medical Inc, BK Medical, Supersonic Imagine, Analogic Corporation.
North America was the largest region in the breast ultrasound market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast ultrasound market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast ultrasound market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the breast ultrasound market by increasing the cost of imported ultrasound systems and imaging components, particularly for automated and advanced 3D/4D devices. Segments such as ABUS systems and portable handheld devices are most affected, with regions like Asia-Pacific including China and India facing higher import duties. This has led to increased prices and supply chain delays. Positively, tariffs encourage local assembly, innovation in cost-effective imaging solutions, and expansion of domestic manufacturing capacities.
The breast ultrasound market research report is one of a series of new reports that provides breast ultrasound market statistics, including breast ultrasound industry global market size, regional shares, competitors with a breast ultrasound market share, detailed breast ultrasound market segments, market trends and opportunities, and any further data you may need to thrive in the breast ultrasound industry. This breast ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Breast ultrasound is a non-invasive imaging method that employs high-frequency sound waves to generate real-time images of the breast’s internal structures. It is frequently used to assess abnormalities detected during a physical exam or mammogram, helping to differentiate between solid lumps and fluid-filled cysts.
The main types of breast ultrasound include conventional breast ultrasound (CBUS) and automated breast ultrasound (ABUS). Conventional breast ultrasound (CBUS) is an affordable, operator-dependent technique that uses a handheld transducer to identify lumps or cysts, particularly in women with dense breast tissue. It incorporates various technologies such as two-dimensional (2D), three-dimensional (3D), four-dimensional (4D) ultrasound, and Doppler ultrasound, and is utilized by a range of end users including hospitals and diagnostic imaging centers.
The breast ultrasound market consists of revenues earned by entities by providing services such as detection of breast abnormalities, evaluation of dense breast tissue, guidance for biopsies, and assessment of symptoms. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast ultrasound market includes sales of transducers, display screens, data storage systems, gel warmers, and ultrasound consoles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The breast ultrasound market size is expected to see rapid growth in the next few years. It will grow to $5.58 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to integration of abUS with full-field digital mammography (ffdm), development of mobile and compact ultrasound units, rising adoption of 3d/4D imaging in hospitals, growth of preventive healthcare and screening programs, increasing investment in diagnostic imaging laboratories. Major trends in the forecast period include rising adoption of automated breast ultrasound (abus) systems, increasing use of portable and handheld ultrasound devices, growth in 3D and 4D ultrasound technologies, expansion of diagnostic imaging laboratories, focus on early breast cancer detection and screening programs.
The rising incidence of breast cancer is anticipated to drive the growth of the breast ultrasound market. Breast cancer originates in breast tissue and can spread to nearby areas or other parts of the body. The increase in breast cancer cases is linked to greater exposure to lifestyle-related risk factors, such as obesity, which affects hormone levels and encourages cancer development. Breast ultrasound plays a crucial role in addressing this rise by offering a reliable, non-invasive method for early detection and precise differentiation of breast abnormalities, particularly in dense breast tissue. For example, in October 2024, the American Cancer Society, a US-based cancer organization, reported that in 2022, there were an estimated 287,850 new cases of invasive breast cancer and 51,400 cases of ductal carcinoma in situ (DCIS) diagnosed among women in the United States. These numbers are expected to increase to approximately 310,720 invasive cases and 56,500 DCIS cases by 2024. This growing incidence is therefore fueling demand in the breast ultrasound market.
Leading companies in the breast ultrasound market are concentrating on developing advanced AI-powered breast ultrasound systems (BUS) to enhance diagnostic speed and early detection, especially for women with dense breast tissue. AI-integrated automated breast ultrasound systems (ABUS) incorporate artificial intelligence to support automated image capture, real-time quality assessment, and lesion detection, thereby reducing scan variability and reliance on operator skill. For instance, in March 2025, GE HealthCare, a US-based healthcare IT provider, launched the Invenia ABUS Premium, a patient-friendly 3D automated breast ultrasound system. This system received premarket approval from the U.S. FDA to improve detection sensitivity when used alongside mammography, addressing challenges related to dense breast tissue masking cancers in conventional screenings. Features include advanced AI tools such as Verisound AI for scan quality evaluation, automatic nipple detection, and a Fast Scan function that speeds scanning by up to 40%. Its non-invasive design also enhances patient comfort, lowers unnecessary biopsies, and eliminates radiation exposure.
In June 2025, RadNet Inc., a US-based provider of diagnostic imaging and digital health services, acquired See-Mode Technologies for an undisclosed sum. This acquisition enables RadNet to integrate See-Mode’s technology into its DeepHealth population health solutions, strengthening its position in AI-driven ultrasound innovation and addressing high demand and capacity challenges in ultrasound imaging. See-Mode Technologies is a Singapore-based company specializing in AI for breast ultrasound imaging.
Major companies operating in the breast ultrasound market are Samsung Electronics Co Ltd, Hitachi Ltd, Siemens Healthineers, Koninklijke Philips NV, GE Healthcare, Hologic Inc, Mindray Medical International Limited, Canon Medical Systems Corporation, Carestream Health Inc, Fujifilm Sonosite Inc, Esaote SpA, Sonoscape Medical Corp, Shantou Institute of Ultrasonic Instruments, Terason, Delphinus Medical Technologies Inc, SonoCine Inc, Clarius Mobile Health Corp, QT Imaging Inc, QView Medical Inc, BK Medical, Supersonic Imagine, Analogic Corporation.
North America was the largest region in the breast ultrasound market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast ultrasound market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast ultrasound market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the breast ultrasound market by increasing the cost of imported ultrasound systems and imaging components, particularly for automated and advanced 3D/4D devices. Segments such as ABUS systems and portable handheld devices are most affected, with regions like Asia-Pacific including China and India facing higher import duties. This has led to increased prices and supply chain delays. Positively, tariffs encourage local assembly, innovation in cost-effective imaging solutions, and expansion of domestic manufacturing capacities.
The breast ultrasound market research report is one of a series of new reports that provides breast ultrasound market statistics, including breast ultrasound industry global market size, regional shares, competitors with a breast ultrasound market share, detailed breast ultrasound market segments, market trends and opportunities, and any further data you may need to thrive in the breast ultrasound industry. This breast ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Breast ultrasound is a non-invasive imaging method that employs high-frequency sound waves to generate real-time images of the breast’s internal structures. It is frequently used to assess abnormalities detected during a physical exam or mammogram, helping to differentiate between solid lumps and fluid-filled cysts.
The main types of breast ultrasound include conventional breast ultrasound (CBUS) and automated breast ultrasound (ABUS). Conventional breast ultrasound (CBUS) is an affordable, operator-dependent technique that uses a handheld transducer to identify lumps or cysts, particularly in women with dense breast tissue. It incorporates various technologies such as two-dimensional (2D), three-dimensional (3D), four-dimensional (4D) ultrasound, and Doppler ultrasound, and is utilized by a range of end users including hospitals and diagnostic imaging centers.
The breast ultrasound market consists of revenues earned by entities by providing services such as detection of breast abnormalities, evaluation of dense breast tissue, guidance for biopsies, and assessment of symptoms. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast ultrasound market includes sales of transducers, display screens, data storage systems, gel warmers, and ultrasound consoles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Breast Ultrasound Market Characteristics
3. Breast Ultrasound Market Supply Chain Analysis
4. Global Breast Ultrasound Market Trends and Strategies
5. Breast Ultrasound Market Analysis of End Use Industries
7. Global Breast Ultrasound Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Breast Ultrasound Total Addressable Market (TAM) Analysis for the Market
9. Breast Ultrasound Market Segmentation
10. Breast Ultrasound Market Regional and Country Analysis
11. Asia-Pacific Breast Ultrasound Market
12. China Breast Ultrasound Market
13. India Breast Ultrasound Market
14. Japan Breast Ultrasound Market
15. Australia Breast Ultrasound Market
16. Indonesia Breast Ultrasound Market
17. South Korea Breast Ultrasound Market
18. Taiwan Breast Ultrasound Market
19. South East Asia Breast Ultrasound Market
20. Western Europe Breast Ultrasound Market
21. UK Breast Ultrasound Market
22. Germany Breast Ultrasound Market
23. France Breast Ultrasound Market
24. Italy Breast Ultrasound Market
25. Spain Breast Ultrasound Market
26. Eastern Europe Breast Ultrasound Market
27. Russia Breast Ultrasound Market
28. North America Breast Ultrasound Market
29. USA Breast Ultrasound Market
30. Canada Breast Ultrasound Market
31. South America Breast Ultrasound Market
32. Brazil Breast Ultrasound Market
33. Middle East Breast Ultrasound Market
34. Africa Breast Ultrasound Market
36. Breast Ultrasound Market Competitive Landscape and Company Profiles
37. Breast Ultrasound Market Other Major and Innovative Companies
40. Breast Ultrasound Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Breast Ultrasound Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses breast ultrasound market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for breast ultrasound? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast ultrasound market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Conventional Breast Ultrasound (CBUS); Automated Breast Ultrasound (ABUS)2) By Technology: Two-Dimensional (2D) Ultrasound; Three-Dimensional (3D) And Four-Dimensional (4D) Ultrasound; Doppler Ultrasound
3) By End-Use: Hospital; Diagnostics Imaging Laboratories; Other End-Uses
Subsegments:
1) By Conventional Breast Ultrasound (CBUS): Portable Or Handheld Ultrasound Systems; Cart Or Trolley-Based Ultrasound Systems; Compact Or Notebook Ultrasound Systems2) By Automated Breast Ultrasound (ABUS): Standalone Automated Breast Ultrasound (ABUS) Systems; Integrated Automated Breast Ultrasound (ABUS) With Full-Field Digital Mammography (FFDM); Mobile Automated Breast Ultrasound (ABUS) Units
Companies Mentioned: Samsung Electronics Co Ltd; Hitachi Ltd; Siemens Healthineers; Koninklijke Philips NV; GE Healthcare; Hologic Inc; Mindray Medical International Limited; Canon Medical Systems Corporation; Carestream Health Inc; Fujifilm Sonosite Inc; Esaote SpA; Sonoscape Medical Corp; Shantou Institute of Ultrasonic Instruments; Terason; Delphinus Medical Technologies Inc; SonoCine Inc; Clarius Mobile Health Corp; QT Imaging Inc; QView Medical Inc; BK Medical; Supersonic Imagine; Analogic Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Breast Ultrasound market report include:- Samsung Electronics Co Ltd
- Hitachi Ltd
- Siemens Healthineers
- Koninklijke Philips NV
- GE Healthcare
- Hologic Inc
- Mindray Medical International Limited
- Canon Medical Systems Corporation
- Carestream Health Inc
- Fujifilm Sonosite Inc
- Esaote SpA
- Sonoscape Medical Corp
- Shantou Institute of Ultrasonic Instruments
- Terason
- Delphinus Medical Technologies Inc
- SonoCine Inc
- Clarius Mobile Health Corp
- QT Imaging Inc
- QView Medical Inc
- BK Medical
- Supersonic Imagine
- Analogic Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.49 Billion |
| Forecasted Market Value ( USD | $ 5.58 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
